Quick Answer
Organogenesis Holdings Inc. reported Total Revenue of $564.17 million for fiscal year 2025.
Organogenesis Holdings Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $564.17M | +17.0% |
| 2024 | $482.04M | +11.3% |
| 2023 | $433.14M | -3.9% |
| 2022 | $450.89M | -3.5% |
| 2021 | $467.36M | +38.2% |
| 2020 | $338.30M | +29.6% |
| 2019 | $260.98M | +34.9% |
| 2018 | $193.45M | -2.5% |
| 2017 | $198.51M | +43.1% |
| 2016 | $138.73M | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $150.86M | +31.0% | +49.4% |
| June 30, 2025 | $101.00M | -22.4% | +16.5% |
| March 31, 2025 | $86.69M | -21.2% | -24.7% |
| September 30, 2024 | $115.18M | +6.1% | -11.6% |
| June 30, 2024 | $130.23M | +11.0% | +18.4% |
| March 31, 2024 | $109.98M | +2.2% | +1.3% |
| September 30, 2023 | $108.53M | -7.1% | -7.5% |
| June 30, 2023 | $117.32M | -3.4% | +9.0% |
- Organogenesis Holdings Inc. showed an increase of +17.0% in Total Revenue compared to the prior fiscal year.
- Over the 2016–2025 period, Organogenesis Holdings Inc.’s total revenue has grown by 306.7% (from $138.73 million to $564.17 million).
- The most recent figure is from Organogenesis Holdings Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: